From Onboarding to Outcomes: The Privacy-First Identity Workflow for Pharma Marketing
A new Experian playbook shows what privacy-first activation looks like in practice, from governed onboarding through partner-enabled measurement.
presented by
What Do the Latest Iteration of Consumer Drug Platforms Offer?
Consumer drug platforms and how they fit into the rise of the consumer in healthcare will be part of the conversation at INVEST Digital Health, scheduled for October 29 in Dallas. Register today!
presented by
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
Debunked Episode 28: A Little More Transparency, A Little More Action
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in the 340B drug discount program.
Debunked Episode 17: Is Big Pharma Prepared for Impact of Trump Administration’s Health Policies?
The Trump administration's healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch.
presented by
How Can RWD Transform the Patient Journey?
A one-size fits most approach to clinical trial recruitment is no longer effective. A webinar discussion emphasized the need for patient-level data to shape each phase of a drug’s lifecycle, from clinical development to market access.
Eliminating Blind Spots in the Patient Journey
The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today!
presented by
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
MedCity Pivot Podcast: A conversation with Gilead Sciences VP Anu Osinusi
Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusi talked about the pharma company's work in HIV and hepatitis and how her personal background informed her team's work in developing a Covid-19 treatment.
Creating an Omnichannel Customer Journey in Healthcare
Improving Customer Experience and Conversion in Healthcare & Life Sciences.
3 ways to reform the pharmacy benefits industry
At the upcoming INVEST Digital Health conference in Dallas set for September 28, in collaboration with Health Wildcatters, a panel discussion on the future of pharmacy benefit managers will be part of the larger conversation on employee benefits. AJ Loiacono, CapitalRx CEO, shared his perspective on the topic.
The power of digital ecosystems to improve pharma supply chain operations
A panel discussion from a recent Microsoft summit offered insights on how tech companies are closely collaborating with the pharma industry as they seek to repair and improve manufacturing supply chain issues exposed by the Covid-19 pandemic.
Where Will AI Deployment Benefit Payers the Most?
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
Digital transformation: Reimagining clinical trial management
Decentralized clinical trial approaches helped the pharma industry navigate through Covid-19. Now it is becoming increasingly clear that there’s a need for a hybrid approach to decentralized clinical trials that considers the perspectives of patients and the impact to clinical trial sites.
How the agile in pharma trend is transforming drug development
Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.
Medical education through Twitter? Pharma’s digital strategy for healthcare
“Most Q&As are happening on Twitter. If you’re not doing social listening you’re losing fresh insights into things like disease states." That was just one of the observations in a new report on how pharma and other life science companies are working with healthcare providers and adapting to improve the patient experience.
Medical education through Twitter? Pharma’s digital strategy for healthcare providers
“Most Q&As are happening on Twitter. If you’re not doing social listening you’re losing fresh insights into things like disease states." That was just one of the observations in a new report on how pharma and other life science companies are working with healthcare providers and adapting to improve the patient experience.
Transforming healthcare in the cloud
A look at how healthcare organizations are collaborating with Microsoft to enhance patient engagement, accelerate healthcare innovation, improve clinical and operational insights, and more.